The genus Yucca comprising of several species is dominant across the chaparrals, canyons and deserts of American South West and Mexico. This genus has long been a source of sustenance and drugs for the Native Americans. In the wake of revived interest in drug discovery from plant sources, this genus has been investigated and startling nutritive and therapeutic capacities have come forth. Apart from the functional food potential, antioxidant, antiinflammation, antiarthritic, anticancer, antidiabetic, antimicrobial, and hypocholesterolaemic properties have also been revealed. Steroidal saponins, resveratrol and yuccaols have been identified to be the active principles with myriad biological actions. To stimulate further research on this genus of multiple food and pharmaceutical uses, this updated review has been prepared with references extracted from MEDLINE database.
filamentosa as medicines and soap. The roots were crushed to make poultice for wound healing. Further, the roots were used to cure gonorrhoea and rheumatism. The Zuni tribe inhabiting the western New Mexico region used Yucca elata sap as hair growth stimulant. The infusion of the crushed leaves of Y. baccata has been used as an antiemetic and the fruits have been eaten raw as a laxative. Skin emollient, soporific agents and antidiabetic are other reported uses. The Chumash Indians consumed root, leaves and flower stalk. Now, this genus is receiving scientific validation and consumer acceptance. A wide array of yucca extract is marketed as capsules, beverages and herbal tea. 'Now Foods', markets a supplement rich in saponins for amelioration of joint pains. 'Nature's way' manufactures a nutraceutical from Y. schidigera stalk. 'Calivita' sells a powder supplement under the brand name 'Pure yucca' to bolster metabolism and detoxification of gut. 'Walmark' trades Y. elata extract claiming its potency to boost metabolism, retard thrombosis and atherosclerosis risks, and ameliorate skin problems. 'Gluten-free remedies' sells root extract of Y. schidigera to support normal flora of intestine and improve immune status. 'Health Aid' markets Y. filamentosa root. High-grade Y. schidigera root extract has a considerable number of uses owing to the prolific plant saponins. Pharma giant 'Swanson' markets yucca capsules for amelioration of joint pain.
Phytochemicals and Mechanisms of Action
Virtually every part of yucca possesses bioactive compounds viz. leaves, shoots, rhizomes, seed pods, flowers and bark. Several phytochemicals of therapeutic importance have been reported in recent times. Saponins are vital components of yucca with broad-spectrum biological properties. These *To whom correspondence should be addressed. E-mail: seemabiotech83@gmail.com steroidal metabolites found in the shoots and rhizomes play key roles in food, cosmetics and pharmaceuticals. Saponins are surface-active sterol or triterpene glycosides with both polar and non-polar moieties. Their antibiotic, haemolytic and hypocholesterolaemic activity and ability to form stable foams in aqueous solution are well documented. The amphipathic nature renders them with surfactant property employable for enhancing penetration of proteins through cell membranes. The ability to reduce surface tensions of substances enables them to regulate blood clots, reduce thrombosis and eliminate heart attack risks. Further, they act as adjuvants for vaccines. Some saponins have been shown to enhance cytotoxicity of drugs against cancer. Steroidal saponins in yucca plant parts are precursors to cortisone, thus believed and to some extent, observed to provide relief from arthritis and rheumatism pain, as in case of Y. schidigera and Y. valida. Also, many polyphenolics including resveratrol and a number of other stilbenes have been reported. The phenolic compounds, yuccaols A, B, C, D and E have been isolated from yucca bark.
1 Acid-hydrolysed fractions of yucca contain both furostanol and spirostanol aglycones. From the seeds of Y. glauca Nutt., sapogenins as sarsasapogenin, markogenin, tigogenin, neo-tigogenin, neo-gitogenin, hecogenin and gloriogenin have been isolated and identified. Ethanolic extract of Y. aloifolia yielded a new spirostanol glycoside. 2 The nuclear transcription factor NFB, stimulates the synthesis of inducible nitric oxide synthase (iNOS), which causes formation of the inflammatory agent nitric oxide. Yuccaols are inhibitors of the NFB, thus anti-inflammatory by nature.
Food and Pharmaceutical Prospects
A substantial number of published reports exist to lend credence to the functional food and pharmaceutical potentials of various yucca species. The biological roles of most-studied yucca species have been presented in Table 1 .
Food Additives
Yucca extracts have acquired GRAS (Generally Recognized As Safe) status, thus approved for incorporation in foods. A saponin fraction was prepared from yucca for food use. 3 The influence of water extract of Y. schidigera powder was evaluated on the foaming potential, structure of candy-foam and its stability during the shelf-life. The steroidal saponin containing extract exerted visible effect on structural attributes viz. dry matter content, hardness, density and porosity. The shelf-life was better than that of α-tocopherol, the freshness retained in a two month period observation. 4 The foaming potential of the extract in beverages and soft drinks has been reviewed. 5 Mechanically sound and moisture-resistant films are sought in food industries for efficient packaging. The possibility of recruiting Y. schidigera-derived surfactant in manufacturing gelatine-based film was assessed. 6 On extrusion, it demonstrated good solubility to produce homogeneous films. Also, it showed better water barrier properties due to the characteristic hydrophobicity of the steroidal moiety of the saponin. However, the desired plasticizing effect was not obtained leading to brittleness which requires further investigation or external plasticizers.
Antioxidant
It was studied that the methanol extract of the bark of Y. periculosa F. Baker, the antioxidants stilbenes and resveratrols. 7 It was observed that resveratrol and the phenolics yuccaols A and C from the bark of Y. schidigera inhibits free radical generation in blood platelets and protect against cardiovascular diseases.
8 The cisplastin-induced oxidative stress-counteracting effect of two phenolic compounds, stilbene and resveratrol sourced from Y. schidigera were assessed on human blood platelets and peripheral blood lymphocytes. 9 Considerable reduction in oxidation of thiol groups of proteins was reported. The antioxidant and antiinflammatory properties of yuccaols (A, B, and C) isolated from Y. schidigera bark were validated further. 10 LC/ESIMS (liquid chromatography coupled to electrospray mass spectrometry) qualitative and an LC/ESIMS/MS (liquid chromatography coupled to tandem electrospray mass spectrometry) quantitative proved to be the ideal strategy for separation and determination of yuccaols and gloriosaols. TEAC assay and ESIMS, NMR data confirmed that gloriosaols A-E extracted from Y. gloriosa has antioxidant activity. 11, 12 Y. schidigera and Y. gloriosa roots and barks contained these bioactive phenolics. 13 The protective effects of Y. schidigera was assessed against oxidative damage induced by acute nitrite intoxication in murine models. 14 The treatment with the extract was found to decrease methemoglobin, blood and tissue malondialdehyde, and tissue nitric oxide concentrations. Further, it increased the glutathione in blood and various tissues. Contrary to the control group, only moderate or mild haemorrhage and hyperaemia (abnormal amount of blood in the capillaries) were seen in kidneys of yucca-fed group. It was inferred that the extract can be used to lessen nitrite-induced oxidative damage and allied complications. The effect of dietary supplementation of Y. schidigera on lipid peroxidation was determined in arsenic-exposed mice. The group administered with different 
Cytotoxicity
Yuccaols (A, B, and C) obtained from Y. schidigera bark were tested on cell proliferation, migration and plateletactivating factor (PAF) biosynthesis. PAF, a potent mediator of inflammation, is known to promote angiogenesis and in vitro migration of endothelial cells and Kaposi's sarcoma cells. Yuccaols completely inhibited the VEGF-stimulated PAF biosynthesis and enhanced its degradation. Western blot analysis revealed that yuccaols reduces the VEGF-induced phosphorylation of p38 and p42/44, thus indicating a possible interference with the mechanism underlying the VEGFstimulated cell proliferation. 10 The antitumor activity of Y. glauca against B16 melanoma has been reviewed. 16 
Antiinflammamtory and Antiarthritic
The anti-inflammatory property of Y. schidigera has been attributed to the resveratrol and yuccaol C content. It reduced the iNOS protein expression via the transcription factors NFB in E. coli LPS-activated macrophage cell line. 1 It was showed that the saponin-containing fraction of the leaves of Y. schottii Engelm. exerts antiinflammatory properties against carrageenin-induced edema in rats. 17 
Antidiabetic
The effects of Y. schidigera, Quillaja saponaria and a mixture of both plants were examined on streptozotocin-induced diabetic rats. After feeding for three weeks, the blood glucose level was found to be significantly lower. The insulin levels increased and the plasma cholesterol and triglyceride levels significantly decreased. Mononuclear leukocyte DNA damage, plasma malondialdehyde, and plasma protein carbonyl levels were found to be significantly lower. 18 
Hypocholesterolaemic
The effects of a blend of partially-purified Y. schidigera and Quillaja saponaria extracts on cholesterol levels in the human blood was studied. Taking 0.9 mg of the mixture (6:4, v:v) a day for a month resulted in decrease of total and LDL cholesterol levels in blood plasma of hyper-cholesterolaemic patients. 25 
Antimicrobial
Antiprotozoal role of saponins have been oft-proved. A saponin fraction from the stems of Y. schidigera exhibited inhibition against certain food-deteriorating, film-forming and dermatophytic yeasts and fungi. 20 The antigiardial effect of oral intake of Y. schidigera powder was investigated by enumeration of gut trophozoites and faecal cysts in infected gerbils and lambs. The butanol extract (6.1 mg) or metronidazole (1 mg) taken once daily for three days reduced the number of trophozoites in the small intestine of infected gerbils. Oral dosing of 50 mg of the extract in eight doses over a period of 3 days reduced trophozoites in the duodenum and jejunum, and eliminated them from the ileum. 10 g powder/ day showed fewer cysts shedding. Further purification may exert more significant anti-giardial effects. 21 The gastrointestinal tract responded to the anti-protozoal activity of saponins. The saponins of Y. schidigera proved as effective as the drug metronidazole in killing tropozoites of Giardia lamblia in the intestine. The mechanism of action was deduced to be due to binding of saponins with microbial membranes and causing pores in them. 22 It was discovered that the leaf extract of Y. smalliana Fern. has also antimicrobial property. 23 The steroidal saponin, yuccalan demonstrated pronounced antifungal activity against Rhizoctonia solani and Fusarium oxysporum. Two spirostanol glycosides isolated from Y. elephantipes showed moderate inhibitory activity against Candida albicans and Cryptococcus neoformans. 24 An antimycotic substance, gloriofucin was prepared that contained spirostanol glycosides, extracted from the dried leaves of Y. gloriosa. 25 
Enhancement of Bioactive Extraction
Extraction of the bioactive constituents by traditional method as Soxhlet serves the purpose; however, for economical efficiency advanced methods prove useful. Ultrasound-assisted extraction yielded better saponin content from ginseng compared to the conventional method. Microwave-assisted extraction using 80% methanol could dramatically reduce the extraction time of ginseng saponins from 12 h using conventional extraction methods to a few seconds. 26 Ultrafiltration and sequential diafiltration can enhance the concentration of saponins of Y. schidigera from 9.3% to 17.2%. 25 In an attempt to enhance metabolites sapogenins, Y. Schidigera rhizome organ culture was conducted. 27 However, the quantification by HPLC did not show any significant improvement in addition of growth regulators.
Discussion
Ample literature exists on the therapeutic potency of 28 The steroidal saponins from Agave utahensis have been reported to show strong cytotoxic activity against HL-60 human promyelocytic leukemia cells. 29 Total steroidal saponins extracted from the rhizomes of Dioscorea zingiberensis exert healing effect on cardiovascular disease. It shows anti-thrombotic activity by prolonging the bleeding time and clotting time in a dose-dependent manner in mice. 30 Steroidal saponins isolated from the rhizomes of Paris polyphylla var. Yunnanensis demonstrated superior cytotoxic effects than cisplatin on human nasopharyngeal carcinoma epithelial cells. The saponins with diosgenin and tetrasaccharide moieties exerted the robust inhibitory effect mediated by apoptosis and cell cycle arrest. 31 The saponins from various yucca species can also be explored for wide spectrum therapeutic potential. There exist sparse findings on the antitumor potential of Y. glauca Nutt., herpes simplex virus type 1 inhibition of yucca leaf protein, antimutagenicity of resveratrol from Y. schidigera against Salmonella typhimurium, anti-yeast action of spirostanol saponins from Y. schidigera. Research undertakings in these promising aspects must be revived.
Going by the yucca-based dietary supplements being commercialized, health attributes of this genus are evident. The emerging clinical evidences of the therapeutic role calls for more research attention. Out of the 40-50 species only a few have been medicinally validated. The Y. brevifolia species, found abundantly in the Mojave National Preserve has been scarcely explored and can be an interesting subject for pharmaceutical discovery. Steroidal saponins have wide structural diversity and significant biological activities. Yucca saponins deserve more investigations in the interest of broader medicinal findings. Traditional knowledge of Native Americans could be consulted for research initiatives. Pharmacognosy will certainly be richer by contribution from this genus. However, the claims must be scientifically verified with more emphasis on human data.
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